With the development of economic and social fields, the world and cities are becoming more and more interconnected. In terms of pharmaceutical industries, has become the world's third largest pharmaceutical market in our country, whether it's medical logistics export or import pharmaceutical logistics, with the improvement of medical insurance, logistics also put forward higher requirements for pharmaceutical products, especially needs low temperature cold storage of medical collection development soon, pharmaceutical cold-chain logistics has entered into a rapid growth, many companies and more investment in the pharmaceutical cold chain logistics, want to dominate them, so, for now well-known medical logistics in our country into larger what? Together with qi xiang logistics, e brother, here is a list of the pharmaceutical cold chain logistics and the logistics of pharmaceutical logistics companies.
Shanghai pharma (group) co. LTD
Shanghai pharmaceutical group co., LTD. Is a national state-owned pharmaceutical industry group based in Shanghai. Company's main business covers medicine research and development and manufacturing, distribution and retail industry chain, in 2012 operating income of 68 billion yuan, according to the evaluation of the China enterprise confederation in 2013 China top 500 enterprises, the company integrated ranking second in the national pharmaceutical industry, is one of the few in China pharmaceutical products and distribution market in the leading position of pharmaceutical listed companies.
Second place: China pharmaceutical group corporation
China pharmaceutical group corporation is the largest and most comprehensive pharmaceutical health industry group in China, which is directly managed by sasac. Focus on the distribution, retail, r&d and production of health-related products such as preventive treatment and diagnostic care.
In 2012, the company realized operating revenue of more than 160 billion yuan, which is the only one in China. Pharmaceutical group has covered 31 provinces, autonomous regions and municipalities directly under the central government of the country's medicine circulation distribution network and integrating with the international level of 30 distribution center, is the nation's largest biomedical research and development, production enterprises, for more than 80% of the national immunization programmes in vaccine production tasks.
Third place: guangzhou pharmaceutical group co. LTD
Guangzhou pharmaceutical group co., LTD., mainly engaged in the research and development of Chinese medicine and plant medicine, chemical raw material medicine and preparation, biological medicine preparation, etc., and manufacture and operate business. Guangyao group has become China's largest pharmaceutical company and guangzhou bio-pharmaceutical health industry leading enterprise. In August 2016, guangzhou pharmaceutical group ranked no. 187 among the "top 500 Chinese enterprises in 2016". In the 2016 annual list of China's pharmaceutical industry, guangyao group topped the list, winning the title of "China's largest pharmaceutical company".
Fourth place: tianjin pharmaceutical group co. LTD
Tianjin pharmaceutical group is a large state-owned enterprise group that is authorized by tianjin municipal government for capital operation and industrial operation. In August 2016, tianjin pharmaceutical group ranked 348 in "2016 China enterprise 500".
No.5: shandong dongjiajiao group co. LTD
Dong - E - E - Jiao Co., ltd. belonging to state-owned China resources group, the company existing staff 4600 people, by the first half of 2017, total assets of 9.8 billion yuan, total market capitalization of over 40 billion yuan, is one of the country's largest donkey-hide gelatin products manufacturing enterprises.
Class products, according to relevant statistics show that vaccine injections, tincture, oral drugs and drugs for external use only, blood products and other cold medicine is a collection of sales amount accounted for about 10% of total sales of medicine circulation enterprises in our country. By the end of 2016, biological medicine, 238 listed companies in our country, covering chemical pharmaceuticals, chemicals, biological products, medical service, medical equipment, medicine, business and Chinese medicine, seven areas throughout the country 30 provinces. The total assets of all listed companies reached 1405182 billion yuan, with a total operating income of 981.6 billion yuan and a net profit of 845.81 billion yuan. Among them, r&d expenditure totaled 23.151 billion yuan, accounting for 2.36% of the total revenue of all listed companies. In June 2015, more than 900 biopharmaceutical enterprises in China have been increasing year by year, mainly in the economic developed areas of bohai sea, Yangtze river delta and pearl river delta. In 2014, the biopharmaceutical industry realized sales revenue of 275 billion yuan, an increase of 13.95 percent year on year, and the profit of the industry reached 32.2 billion yuan, an increase of 11.82 percent year on year, in a relatively fast growth stage.
According to qi xiang logistics, currently, enterprises engaged in pharmaceutical logistics can be divided into traditional pharmaceutical enterprises and social logistics enterprises. Among them, the traditional drug firms for the layout of the logistics mainly concentrated in the warehouse, social logistics is the main force of medicine circulation in the transport process, to rule out a small amount of self-built regional logistics resources, including big drug firms and all kinds of electric business platform, and its drug transnational, cross-regional, across the province transportation with 80% ~ 90% was accomplished by the society logistics.
The pharmaceutical enterprise self-built logistics and social logistics have advantages in medicine cold chain. Due to the historical reasons of policies and other historical reasons, social logistics is relatively deficient in medical and storage resources, but has great advantages in network resources. The possibility of self-built distribution of medical e-commerce platform is not very large. Self-built transport is not in conformity with the medical cost structure of electric business platform, to build a medical cold warehouse cost in one hundred million yuan of above, even transform to tens of millions, and large cold car carrier each cost will more than millions, only 10% of the gross profit for each order forms is unthinkable. The personage inside course of study says, in the future, the third party logistics (such as: thestrals cheung logistics, the specialty is engaged in third-party service flow transportation, from the pharmaceutical cold-chain transportation solutions to the resource integration, one-stop service, the regional coverage to nearly 200
The state and the region are still the main transport forces of the pharmaceutical industry.
Domestic/international pharmaceutical logistics import and export, pharmaceutical logistics transport contact number: 0755-892082808280929349774
Company address: 4th floor, block A, lijing business district, no.57, busha road, longgang district, shenzhen